Agfa-Gevaert NV (LON:0MFU)
London · Delayed Price · Currency is GBP · Price in EUR | Market Cap | 50.14M -67.2% |
| Revenue (ttm) | 943.03M -4.4% |
| Net Income | -55.01M |
| EPS | -0.36 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | 8.12 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,934 |
| Open | 0.3800 |
| Previous Close | 0.3780 |
| Day's Range | 0.3770 - 0.3770 |
| 52-Week Range | 0.3660 - 1.1580 |
| Beta | 0.53 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 26, 2026 |
About Agfa-Gevaert NV
Agfa-Gevaert NV develops, manufactures, and markets various analog and digital systems in Belgium and internationally. The company provides healthcare’s enterprise imaging platform. It also offers printers, inks, and software for sign and display and packaging printing companies; inkjet inks and fluids for various industrial inkjet applications, such as signs, displays, billboards, promotional materials, packaging, leather goods, laminated flooring, and decorative materials, as well as for printed electronics industry; electrolysis membranes to... [Read more]
Financial Performance
In 2025, Agfa-Gevaert NV's revenue was 1.09 billion, a decrease of -4.57% compared to the previous year's 1.14 billion. Losses were -71.00 million, -22.83% less than in 2024.
Financial numbers in EUR Financial StatementsNews
Agfa-Gevaert announces changes to the Board of Directors
June 3, 2026 – 5.40 PM CET Regulated information Agfa-Gevaert announces changes to the Board of Directors Mortsel, Belgium – June 3, 2026 – 5.40 p.m. CET Agfa-Gevaert announces that its Board of Direc...
Agfa-Gevaert announces resignation of Michel Govaert from the Board of Directors
May 20, 2026 – 5.40 PM CET Regulated information Agfa-Gevaert announces resignation of Michel Govaert from the Board of Directors Mortsel, Belgium – May 20, 2026 – 5.40 p.m. CET Agfa-Gevaert announces...
Annual General Meeting of Agfa-Gevaert NV
May 12, 2026 – 5.40 PM CET Regulated information Annual General Meeting of Agfa-Gevaert NV Mortsel, Belgium – May 12, 2026 – 5.40 p.m. CET At Agfa-Gevaert's Annual General Meeting, the 2025 financial ...
Agfa-Gevaert NV Earnings Call Transcript: Q1 2026
Q1 2026 saw robust top-line growth in film and digital printing, strong EBITDA gains from cost savings, and a successful SaaS transition in HealthCare IT. ZIRFON faces a tough 2026, but a rebound is expected in 2027, while overall group outlook remains unchanged.
Agfa-Gevaert NV Earnings release: Q1 2026
Agfa-Gevaert NV released its Q1 2026 earnings on May 12, 2026, summarizing the period's financial results.
Agfa-Gevaert NV Slides: Q1 2026
Agfa-Gevaert NV has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 12, 2026.
Agfa-Gevaert delivers robust Q1 2026 performance amid market challenges
Regulated information May 12, 2026 - 7:45 a.m. CET Agfa-Gevaert delivers robust Q1 2026 performance amid market challenges
Agfa-Gevaert: Convening of Annual General Meeting
April 10, 2026 Regulated information Agfa-Gevaert: Convening of Annual General Meeting Mortsel, Belgium – April 10, 2026 Unofficial translation from the Dutch version AGFA-GEVAERT NAAMLOZE VENNOOTSCHA...
Agfa-Gevaert NV Earnings Call Transcript: Q4 2025
Q4 delivered record EBITDA and strong cash flow, offsetting a challenging year marked by Radiology decline and currency headwinds. HealthCare IT cloud transition accelerated, DPS faced setbacks, and restructuring costs will pressure 2026 cash flow, but profitability is expected to improve.
Agfa-Gevaert NV Earnings release: Q4 2025
Agfa-Gevaert NV released its Q4 2025 earnings on March 11, 2026, summarizing the period's financial results.
Agfa-Gevaert NV Slides: Q4 2025
Agfa-Gevaert NV has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 11, 2026.
Agfa-Gevaert Group in 2025: strong Q4 profitability and free cash flow – good step-up in FY profitability in HealthCare IT and Digital Print & Chemicals
Regulated information March 11, 2026 - 7:45 a.m. CET Agfa-Gevaert Group in 2025: strong Q4 profitability and free cash flow – good step-up in FY profitability in HealthCare IT and Digital Pri...
Agfa-Gevaert NV Earnings Call Transcript: Q3 2025
Q3 saw a sharp decline in medical film and a rapid shift to cloud in HealthCare IT, impacting short-term results but driving strong order intake. Cost-cutting and restructuring are being accelerated, with positive cash flow and improved net results year-over-year.
Agfa-Gevaert NV Earnings release: Q3 2025
Agfa-Gevaert NV released its Q3 2025 earnings on November 13, 2025, summarizing the period's financial results.
Agfa-Gevaert NV Slides: Q3 2025
Agfa-Gevaert NV has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 13, 2025.
Agfa-Gevaert NV Earnings Call Transcript: Q2 2025
H1 2025 saw strong HealthCare IT growth and improved cash flow, but rapid decline in the medical film market and subdued digital printing and green hydrogen segments weighed on EBITDA. A EUR38 million Agfa Photo gain boosted net results, and further restructuring is underway.
Agfa-Gevaert NV Earnings release: Q2 2025
Agfa-Gevaert NV released its Q2 2025 earnings on August 27, 2025, summarizing the period's financial results.
Agfa-Gevaert NV Slides: Q2 2025
Agfa-Gevaert NV has posted slides in relation to its Q2 2025 quarterly earnings report, which was published on August 27, 2025.
Agfa-Gevaert NV signs new revolving credit facility - Regulated information - Contains inside information
August 1, 2025 – 6.00 PM CET Regulated information - Contains inside information Agfa-Gevaert NV signs new revolving credit facility Mortsel, Belgium – August 1, 2025 – 6.00 p.m. CET Agfa-Gevaert NV h...
Arbitral Tribunal acting under ICC Rules of Arbitration issues final award in an arbitration between Agfa-Gevaert and the insolvency receiver of AgfaPhoto GmbH
June 27, 2025 - 1.45 PM CET Regulated information – Contains inside information Arbitral Tribunal acting under ICC Rules of Arbitration issues final award in an arbitration between Agfa-Gevaert and th...
Agfa-Gevaert NV Earnings Call Transcript: Q1 2025
Q1 2025 saw stable results with strong growth in healthcare IT offsetting declines in film and radiology, especially in China. The outlook for healthcare IT is upgraded, while DPC and ZIRFON face subdued growth due to market delays. Cost-saving measures and innovation support future performance.
Agfa-Gevaert NV Earnings release: Q1 2025
Agfa-Gevaert NV released its Q1 2025 earnings on May 14, 2025, summarizing the period's financial results.
Agfa-Gevaert NV Slides: Q1 2025
Agfa-Gevaert NV has posted slides in relation to its Q1 2025 quarterly earnings report, which was published on May 14, 2025.
The Agfa-Gevaert Group in Q1 2025: adjusted EBITDA stable versus Q1 2024 – improved mix and good cost control compensated for film market decline
Regulated information May 14, 2025 - 7:45 a.m. CET The Agfa-Gevaert Group in Q1 2025: adjusted EBITDA stable versus Q1 2024 – improved mix and good cost control compensated for film market de...
Annual General Meeting of Agfa-Gevaert NV - regulated information
May 13, 2025 – 5.40 PM CET Regulated information Annual General Meeting of Agfa-Gevaert NV Mortsel, Belgium – May 13, 2025 – 5.40 p.m. CET At Agfa-Gevaert's Annual General Meeting, the 2024 financial ...